Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sodium folate |
Is a |
False |
Folic acid |
Inferred relationship |
Some |
|
Product containing folinic acid (medicinal product) |
Is a |
False |
Folic acid |
Inferred relationship |
Some |
|
Tetrahydrofolic acid |
Is a |
False |
Folic acid |
Inferred relationship |
Some |
|
Dihydrofolic acid |
Is a |
False |
Folic acid |
Inferred relationship |
Some |
|
Folic acid measurement (procedure) |
Has measured component |
False |
Folic acid |
Inferred relationship |
Some |
|
Plasma folate measurement |
Has measured component |
False |
Folic acid |
Inferred relationship |
Some |
|
Accidental folic acid poisoning |
Causative agent |
False |
Folic acid |
Inferred relationship |
Some |
|
Intentional folic acid poisoning |
Causative agent |
False |
Folic acid |
Inferred relationship |
Some |
|
forgiftning med folsyre, uvist med hvilken hensigt |
Causative agent |
False |
Folic acid |
Inferred relationship |
Some |
1 |
bivirkning af jern og folsyre |
Causative agent |
False |
Folic acid |
Inferred relationship |
Some |
1 |
Folic acid adverse reaction |
Causative agent |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Folic acid overdose |
Causative agent |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Accidental folic acid overdose |
Causative agent |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Intentional folic acid overdose |
Causative agent |
True |
Folic acid |
Inferred relationship |
Some |
1 |
overdosis af folsyre, uvist med hvilken hensigt |
Causative agent |
False |
Folic acid |
Inferred relationship |
Some |
1 |
Poisoning by folic acid |
Causative agent |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Folic acid measurement, serum |
Has measured component |
False |
Folic acid |
Inferred relationship |
Some |
|
Folic acid measurement, RBC |
Has measured component |
False |
Folic acid |
Inferred relationship |
Some |
|
Whole blood folate measurement |
Has measured component |
False |
Folic acid |
Inferred relationship |
Some |
|
Blood folate NOS |
Has measured component |
False |
Folic acid |
Inferred relationship |
Some |
|
Folic acid radioimmunoassay |
Component |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Radiobioassay - folic acid |
Component |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Folic acid measurement (procedure) |
Component |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Plasma folate measurement |
Component |
False |
Folic acid |
Inferred relationship |
Some |
2 |
Folic acid measurement, serum |
Component |
False |
Folic acid |
Inferred relationship |
Some |
2 |
Folic acid measurement, RBC |
Component |
False |
Folic acid |
Inferred relationship |
Some |
2 |
Whole blood folate measurement |
Component |
False |
Folic acid |
Inferred relationship |
Some |
2 |
Blood folate NOS |
Component |
False |
Folic acid |
Inferred relationship |
Some |
|
Allergy to folic acid (finding) |
Causative agent |
False |
Folic acid |
Inferred relationship |
Some |
|
Product containing precisely folic acid 100 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Folic acid 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Folic acid 400 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folsyre 2,5 mg/5 ml sukkerfri syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folsyre 400 µg/5 ml sukkerfri oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Product containing precisely folic acid 400 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folsyre 300 µg/5 ml sukkerfri syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folsyre 4 mg/5 ml sukkerfri syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folsyre 5 mg/5 ml sukkerfri syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Ferrous fumarate 324 mg and folic acid 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folsyre 0,8 mg + jern 15 mg dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folsyre 1 mg + jern 100 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Leucovorin preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Product containing folic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Folinic acid preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folsyretilskud |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Product containing folic acid and iron (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Some |
2 |
ferrosulfat 150 mg + folsyre 500 µg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
ferrosulfat 325 mg + folsyre 350 µg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
ferriammoniumcitrat 80 mg/5 ml + folsyre 500 µg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
ferrosulfat 160 mg + folsyre 400 µg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
ferriammoniumcitrat + folsyre 80 mg/2,5 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Product containing precisely ascorbic acid 10 milligram and ferrous gluconate 250 milligram and folic acid 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Product containing precisely ferrous fumarate 322 milligram and folic acid 350 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folsyre + pyridoxin + cyanocobalamin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
3 |
folinsyre 10 mg/ml injektionsvæske, opløsning, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, ampul a 2,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, hætteglas a 17,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, hætteglas a 35 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 7,5 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 10 mg/ml injektionsvæske, opløsning, hætteglas a 30 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Folinic acid 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 3 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 15 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 30 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 3 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 100 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 400 mg/8 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 900 mg/18 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
levofolinsyre 50 mg/5 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
folinsyre 50 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Folinic acid 15mg injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Product containing folinic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Accidental folic acid poisoning |
Causative agent |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Intentional folic acid poisoning |
Causative agent |
True |
Folic acid |
Inferred relationship |
Some |
1 |
allergi over for jern og folsyre |
Causative agent |
False |
Folic acid |
Inferred relationship |
Some |
|
Product containing ferrous fumarate and folic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Some |
2 |
Product containing ferrous gluconate and folic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Some |
2 |
Product containing ferrous sulfate and folic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Some |
2 |
Product containing ferric ammonium citrate and folic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Some |
2 |
Levomefolic acid |
Is a |
False |
Folic acid |
Inferred relationship |
Some |
|
Administration of prophylactic folic acid (procedure) |
Direct substance |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Folic acid 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Administration of prophylactic folic acid (procedure) |
Direct substance |
False |
Folic acid |
Inferred relationship |
Some |
1 |
Allergy to folic acid (finding) |
Causative agent |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Cyanocobalamin + folic acid |
Is a |
False |
Folic acid |
Inferred relationship |
Some |
|
Ferrous salt + folic acid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Product containing ferrous salt and folic acid in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
|
Product containing folic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Product containing precisely ferrous fumarate 322 milligram and folic acid 350 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Folic acid |
Inferred relationship |
Some |
1 |
Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
2 |
Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Folic acid |
Inferred relationship |
Some |
2 |
Product containing precisely ascorbic acid 10 milligram and ferrous gluconate 250 milligram and folic acid 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Folic acid |
Inferred relationship |
Some |
1 |
Product containing precisely folic acid 100 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
1 |
Product containing precisely folic acid 100 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Folic acid 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
1 |
Folic acid 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Folic acid 400 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
1 |
Folic acid 400 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Folic acid |
Inferred relationship |
Some |
1 |
Product containing precisely folic acid 400 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Folic acid |
Inferred relationship |
Some |
1 |